Article
How Modulator Binding at the Amyloidβ-γ-Secretase Interface Enhances Substrate Binding and Attenuates Membrane Distortion.
Journal of medicinal chemistry - 28 Dec 2023
Chen Shu-Yu, Koch Matthias, Chávez-Gutiérrez Lucía, Zacharias Martin
Abstract excerpt
Inhibition of γ-secretase, an intramembrane protease, to reduce secretion of Amyloid-β (Aβ) peptides has been considered for treating Alzheimer's disease. However, γ-secretase inhibitors suffer from severe side effects. As an alternative, γ-secretase modulators (GSM) reduce the generation of toxic peptides by enhancing the cleavage processivity without diminishing the enzyme activity. Starting from a known...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
